Volume : 10, Issue : 11, November – 2023

Title:

PREVALENCE OF ECZEMA AND ASSOCIATED RISK FACTORS AMONG SAUDI POPULATION: A CROSS-SECTIONAL STUDY

Authors :

Miasser Mustafa Alarnauty, Kawthar Abdullah Al Muhandir, Ahmed Saleh Al saed, Sarah Mohammed Alqahtani, Yasamiyan Nawaf Aljazi, Majed Eid Alhejaili, Baraah Mohammed Alhashidi, Ghaliah Talal Futayh, Fatema Abdulwahed Ahmed, Shroq Saleh Al-matari5, Elan Faiz Alasmari, Ahlam Ahmed Aldeghari, Fatimah Rashed Alanazi, Alhanouf Hamdan Alanazi and Badriyh Mufadhi Alanazi

Abstract :

Objective: To determine the Prevalence and risk factors of eczema patients among the population in the Kingdom of Saudi Arabia.
Methods: This research will employ a cross-sectional study design. This design is suitable for investigating the prevalence of eczema and identifying associated risk factors within the Saudi population.
Results: The study included 612 participants. The most frequent gender among them was Female (n= 444, 72.5%) followed by Male (n= 168, 27.5%). The most frequent age among study participants was 18-28 years old (n= 322, 52.6%) followed by 29-39 years old (n= 138, 22.5%). Participants were asked if they have eczema now. There 82 had eczema (13.4%), and 530 participants didn’t have eczema (86.6%). Nature of the weather in the area where the participants live among the study with most of them having dry weather (n= 337, 55.1%) followed by humid weather (n= 275, 44.9%).
Conclusion: Study results showed that most of the study participants are Female according to their gender. The most common of the participants were don’t have eczema. Most of them live in dry weather. In addition, most of study participants had good social connections.

Cite This Article:

Please cite this article in press Hoda Jehad Abousada et al, Prevalence Of Eczema And Associated Risk Factors Among Saudi Population: A Cross-Sectional Study., Indo Am. J. P. Sci, 2023; 10 (11).

Number of Downloads : 10

References:

1. A population-based survey of eczema prevalence in the United States. Hanifin JM, Reed ML. Dermatitis. 2007;18:82–91.
2. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. J Allergy Clin Immunol. 2009;124:1251–1258.
3. Prevalence and influencing risk factors of eczema among preschool children in Urumqi city: a cross-sectional survey. Shi H, Wan G, Wang T, et al. BMC Pediatr. 2021;21:347.
4. Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus. Cramer C, Link E, Bauer CP, et al. Allergy. 2011;66:68–75.
5. What causes flares of eczema in children? Langan SM, Silcocks P, Williams HC. Br J Dermatol. 2009;161:640–646.
6. Lifetime prevalence of childhood eczema and the effect of indoor environmental factors: Analysis in Hispanic and non-Hispanic white children. Kim HB, Zhou H, Kim JH, Habre R, Bastain TM, Gilliland FD. Allergy Asthma Proc. 2016;37:64–71.
7. High prevalence of eczema among preschool children related to home renovation in China: A multi-city-based cross-sectional study. Sun C, Zhang J, Huang C, et al. Indoor Air. 2019;29:748–760.
8. Eczema. Sohn A, Frankel A, Patel RV, Goldenberg G. Mt Sinai J Med. 2011;78:730–739.
9. Climatic factors are associated with childhood eczema prevalence in the United States. Silverberg JI, Hanifin J, Simpson EL. J Invest Dermatol. 2013;133:1752–1759.
10. ‘Dampness’ at home and its association with airway, nose, and skin symptoms among 10,851 preschool children in Sweden: a cross-sectional study. Bornehag CG, Sundell J, Hagerhed-Engman L, Sigsggard T, Janson S, Aberg N. Indoor Air. 2005;15 Suppl 10:48–55.
11. Perinatal factors and the risk of atopic dermatitis: a cohort study. Parazzini F, Cipriani S, Zinetti C, et al. Pediatr Allergy Immunol. 2014;25:43–50.
12. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
13. Fukunaga N, Okada Y, Konishi Y, Murashita T, Koyama T. Pay attention to valvular disease in the presence of atopic dermatitis. Circ J. 2013;77(7):1862–1866.
14. Sheary B, Harris MF. Cessation of long-term topical steroids in adult atopic dermatitis: a prospective cohort study. Dermatitis. 2020;31(5):316–320.
15. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926.
16. Grant L, Seiding Larsen L, Trennery C, Silverberg JI, Abramovits W, Simpson EL, et al. Conceptual model to illustrate the symptom experience and humanistic burden associated with atopic dermatitis in adults and adolescents. Dermatitis. 2019;30(4):247–254.
17. World Bank Country and Lending Groups—World Bank Data help desk. 2020. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed 17 Oct 2023.
18. Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23(8 Suppl):S115–S123.
19. Silverwood RJ, Mansfield KE, Mulick A, Wong AYS, Schmidt SAJ, Roberts A, et al. Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998–2016. J Allergy Clin Immunol. 2021;147(5):1753–1763.
20. World Bank. Consumer price index (2010 = 100) | Data; 2021. https://data.worldbank.org/indicator/FP.CPI.TOTL. Accessed 17 Oct 2023.
21. Andersen L, Nyeland ME, Nyberg F. Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A. Br J Dermatol. 2020;182(5):1176–83.
22. Le PH, Vo TQ, Nguyen NH. Quality of life measurement alteration among Vietnamese: impact and treatment benefit related to eczema. J Pak Med Assoc. 2019;69(Suppl 2):S49–S56.
23. Lee SH, Lee SH, Lee SY, Lee B, Lee SH, Park YL. Psychological health status and health-related quality of life in adults with atopic dermatitis: a nationwide cross-sectional study in South Korea. Acta Derm Venereol. 2018;98(1):89–97.
24. Misery L, Seneschal J, Reguiai Z, Merhand S, Héas S, Huet F, et al. The impact of atopic dermatitis on sexual health. J Eur Acad Dermatol Venereol. 2019;33(2):428–432.
25. Katoh N, Saeki H, Kataoka Y, Etoh T, Teramukai S, Takagi H, et al. Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): baseline characteristics, treatment history and disease burden. J Dermatol. 2019;46(4):290–300.
26. Ameen M, Rabe A, Blanthorn-Hazell S, Millward R. The prevalence and clinical profile of atopic dermatitis (AD) in England—a population based linked cohort study using clinical practice research datalink (CPRD) and Hospital episode statistics (HES) Value Health. 2020;23(s2):S745.
27. Augustin M, Langenbruch A, Blome C, Gutknecht M, Werfel T, Ständer S, et al. Characterizing treatment-related patient needs in atopic eczema: insights for personalized goal orientation. J Eur Acad Dermatol Venereol. 2020;34(1):142–152.
28. Chee A, Branca L, Jeker F, Vogt DR, Schwegler S, Navarini A, et al. When life is an itch: What harms, helps, and heals from the patients’ perspective? Differences and similarities among skin diseases. Dermatol Ther. 2020.
29. Falissard B, Simpson EL, Guttman-Yassky E, Papp KA, Barbarot S, Gadkari A, et al. Qualitative assessment of adult patients’ perception of atopic dermatitis using natural language processing analysis in a cross-sectional study. Dermatology and Therapy. 2020;10(2):297–305.
30. Ng MSY, Tan S, Chan NHQ, Foong AYW, Koh MJA. Effect of atopic dermatitis on quality of life and its psychosocial impact in Asian adolescents. Australas J Dermatol. 2018;59(2):e114–e117.
31. Wang X, Li LF, Zhao DY, Shen YW. Prevalence and clinical features of atopic dermatitis in China. Biomed Res Int. 2016;2016:2568301.
32. Ferrucci S, Casazza G, Angileri L, Tavecchio S, Germiniasi F, Berti E, et al. Clinical response and quality of life in patients with severe atopic dermatitis treated with dupilumab: a single-center real-life experience. J Clin Med. 2020;9(3):791.
33. Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Chavda R, et al. Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients. Ann Allergy Asthma Immunol. 2020;124(3):261–266.
34. Lei DK, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Sacotte R, et al. Validation of patient-reported outcomes information system sleep disturbance and sleep-related impairment in adults with atopic dermatitis. Br J Dermatol. 2020;183(5):875–882.
35. Nettis E, Ferrucci SM, Ortoncelli M, Pellacani G, Foti C, Di Leo E, et al. Use of dupilumab for 543 adult patients with moderate-to-severe atopic dermatitis: a multicenter, retrospective study. J Investig Allergol Clin Immunol. 2020;32:124–132.
36. Heckman CJ, Riley M, Valdes-Rodriguez R, Yosipovitch G. Development and initial psychometric properties of two itch-related measures: scratch intensity and impact, sleep-related itch and scratch. J Invest Dermatol. 2020;140(11):2138–45.e1.
37. Heratizadeh A, Haufe E, Stölzl D, Abraham S, Heinrich L, Kleinheinz A, et al. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREAT Germany. J Eur Acad Dermatol Venereol. 2020;34(6):1263–1272.
38. Wei W, Ghorayeb E, Andria M, Walker V, Schnitzer J, Kennedy M, et al. A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): baseline treatment patterns and unmet needs assessment. Ann Allergy Asthma Immunol. 2019;123(4):381–8.e2.
39. Boehm D, Schmid-Ott G, Finkeldey F, John SM, Dwinger C, Werfel T, et al. Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermatitis. 2012;67(4):184–192.
40. Chrostowska-Plak D, Reich A, Szepietowski JC. Relationship between itch and psychological status of patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2013;27(2):e239–e242.